161 related articles for article (PubMed ID: 31113567)
1. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study.
Leela-Arporn R; Ohta H; Nagata N; Sasaoka K; Tamura M; Dermlim A; Nisa K; Morishita K; Sasaki N; Nakamura K; Takagi S; Hosoya K; Takiguchi M
Vet J; 2019 Jun; 248():74-78. PubMed ID: 31113567
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014.
O'Neill DG; Scudder C; Faire JM; Church DB; McGreevy PD; Thomson PC; Brodbelt DC
J Small Anim Pract; 2016 Jul; 57(7):365-73. PubMed ID: 27279104
[TBL] [Abstract][Full Text] [Related]
3. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs.
Hess RS; Kass PH; Van Winkle TJ
J Vet Intern Med; 2003; 17(4):489-94. PubMed ID: 12892299
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of progressive vacuolar hepatopathy in Scottish Terriers with and without hepatocellular carcinoma: 114 cases (1980-2013).
Cortright CC; Center SA; Randolph JF; McDonough SP; Fecteau KA; Warner KL; Chiapella AM; Pierce RL; Graham AH; Wall LJ; Heidgerd JH; Degen MA; Lucia PA; Erb HN
J Am Vet Med Assoc; 2014 Oct; 245(7):797-808. PubMed ID: 25229531
[TBL] [Abstract][Full Text] [Related]
5. Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis.
Hess RS; Kass PH; Ward CR
J Am Vet Med Assoc; 1998 Jun; 212(12):1889-91. PubMed ID: 9638187
[TBL] [Abstract][Full Text] [Related]
6. Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals.
Hoffman JM; Lourenço BN; Promislow DEL; Creevy KE
J Small Anim Pract; 2018 Nov; 59(11):681-690. PubMed ID: 30039567
[TBL] [Abstract][Full Text] [Related]
7. Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma.
Matsuyama A; Takagi S; Hosoya K; Kagawa Y; Nakamura K; Deguchi T; Takiguchi M
N Z Vet J; 2017 Sep; 65(5):227-231. PubMed ID: 28441916
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018).
Moyer J; Lopez DJ; Balkman CE; Sumner JP
Open Vet J; 2021; 11(1):144-153. PubMed ID: 33898296
[TBL] [Abstract][Full Text] [Related]
9. Gall bladder mucoceles and their association with endocrinopathies in dogs: a retrospective case-control study.
Mesich ML; Mayhew PD; Paek M; Holt DE; Brown DC
J Small Anim Pract; 2009 Dec; 50(12):630-5. PubMed ID: 19954439
[TBL] [Abstract][Full Text] [Related]
10. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.
Lapsley JM; Wavreille V; Barry S; Dornbusch JA; Chen C; Leeper H; Bertran J; Scavelli D; Liptak JM; Wood C; Shamir S; Rosenbaum C; Montinaro V; Wustefeld-Janssens B; Sterman A; Chik C; Singh A; Collins J; Selmic LE
Vet Comp Oncol; 2022 Sep; 20(3):697-709. PubMed ID: 35488436
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of cytologic features of well-differentiated hepatocellular carcinoma in dogs.
Masserdotti C; Drigo M
Vet Clin Pathol; 2012 Sep; 41(3):382-90. PubMed ID: 22616765
[TBL] [Abstract][Full Text] [Related]
13. [Familial canine pituitary-dependent hyperadrenocorticism in wirehaired Dachshunds].
Stritzel S; Mischke R; Philipp U; Kleinschmidt S; Wohlsein P; Stock KF; Distl O
Berl Munch Tierarztl Wochenschr; 2008; 121(9-10):349-58. PubMed ID: 18822606
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma.
Lai YC; Ushio N; Rahman MM; Katanoda Y; Ogihara K; Naya Y; Moriyama A; Iwanaga T; Saitoh Y; Sogawa T; Sunaga T; Momoi Y; Izumi H; Miyoshi N; Endo Y; Fujiki M; Kawaguchi H; Miura N
Vet Comp Oncol; 2018 Jun; 16(2):288-296. PubMed ID: 29314614
[TBL] [Abstract][Full Text] [Related]
15. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
Ford SL; Feldman EC; Nelson RW
J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
[TBL] [Abstract][Full Text] [Related]
16. Canine serum thermostable alkaline phosphatase isoenzyme from a dog with hepatocellular carcinoma.
Fukui Y; Sato J; Sato R; Yasuda J; Naito Y
J Vet Med Sci; 2006 Oct; 68(10):1129-32. PubMed ID: 17085898
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.
Nagata N; Kojima K; Yuki M
J Vet Intern Med; 2017 Jan; 31(1):22-28. PubMed ID: 27906457
[TBL] [Abstract][Full Text] [Related]
18. Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002).
Liptak JM; Dernell WS; Monnet E; Powers BE; Bachand AM; Kenney JG; Withrow SJ
J Am Vet Med Assoc; 2004 Oct; 225(8):1225-30. PubMed ID: 15521445
[TBL] [Abstract][Full Text] [Related]
19. Prognosis for acute nontraumatic hemoperitoneum in the dog: a retrospective analysis of 60 cases (2003-2006).
Aronsohn MG; Dubiel B; Roberts B; Powers BE
J Am Anim Hosp Assoc; 2009; 45(2):72-7. PubMed ID: 19258418
[TBL] [Abstract][Full Text] [Related]
20. Hyperalbuminemia associated with hepatocellular carcinoma in a dog.
Cooper ES; Wellman ML; Carsillo ME
Vet Clin Pathol; 2009 Dec; 38(4):516-20. PubMed ID: 19473332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
